6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
27m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
28m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
52m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
52m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
52m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Nurexone Biologic Inc. (V:NRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production

NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update

NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026

NurExone Biologic's U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization

NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization

Financials

Revenue

CA$0

Market Cap

CA$58.94 M

EPS

-0.11

Community Chat

Ask AI